Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

620 ARTÍCULOS , VIENDO DEL 256 AL 270

Deconstructing Alzheimer's Disease: How to Bridge the Gap between Experimental Models and the Human Pathology?

Vignon A, Salvador-Prince L, Lehmann S, Perrier V, Torrent J.

Int J Mol Sci. 2021 Aug 16;22(16):8769. doi: 10.3390/ijms22168769.

Decrypting the potential role of α-lipoic acid in Alzheimer's disease

Kaur D, Behl T, Sehgal A, Singh S, Sharma N, Chigurupati S, Alhowail A, Abdeen A, Ibrahim SF, Vargas-De-La-Cruz C, Sachdeva M, Bhatia S, Al-Harrasi A, Bungau S.

Life Sci. 2021 Nov 1;284:119899. doi: 10.1016/j.lfs.2021.119899. Epub 2021 Aug 25.

A Review of Techniques for Biodelivery of Nerve Growth Factor (NGF) to the Brain in Relation to Alzheimer's Disease

Mitra S, Gera R, Linderoth B, Lind G, Wahlberg L, Almqvist P, Behbahani H, Eriksdotter M.

Adv Exp Med Biol. 2021;1331:167-191. doi: 10.1007/978-3-030-74046-7_11.

NGF Released from Blood Cells or Collagen Hydrogels as a Therapeutic Target in Alzheimer's Disease?

Humpel C.

Adv Exp Med Biol. 2021;1331:193-202. doi: 10.1007/978-3-030-74046-7_12.

Current druggable targets for therapeutic control of Alzheimer's disease

Gupta GL, Samant NP.

Contemp Clin Trials. 2021 Oct;109:106549. doi: 10.1016/j.cct.2021.106549. Epub 2021 Aug 28.

A systematic review of carbohydrate-based bioactive molecules for Alzheimer's disease

Bajad NG, Swetha R, Gutti G, Singh M, Kumar A, Singh SK.

Future Med Chem. 2021 Oct;13(19):1695-1711. doi: 10.4155/fmc-2021-0109. Epub 2021 Sep 2.

Roles of microglia in Alzheimer's disease and impact of new findings on microglial heterogeneity as a target for therapeutic intervention

Takata K, Ginhoux F, Shimohama S.

Biochem Pharmacol. 2021 Oct;192:114754. doi: 10.1016/j.bcp.2021.114754. Epub 2021 Sep 1.

Extensive metabolism of flavonoids relevant to their potential efficacy on Alzheimer's disease

Xia H.

Drug Metab Rev. 2021 Nov;53(4):563-591. doi: 10.1080/03602532.2021.1977316. Epub 2021 Oct 1.

Breaker peptides against amyloid-β aggregation: a potential therapeutic strategy for Alzheimer's disease

Ghosh N, Kundu LM.

Future Med Chem. 2021 Oct;13(20):1767-1794. doi: 10.4155/fmc-2021-0184. Epub 2021 Sep 9.

Copper, Iron, Selenium and Lipo-Glycemic Dysmetabolism in Alzheimer's Disease

Aaseth J, Skalny AV, Roos PM, Alexander J, Aschner M, Tinkov AA.

Int J Mol Sci. 2021 Aug 31;22(17):9461. doi: 10.3390/ijms22179461.

GPR40 Agonist Ameliorate Pathological Neuroinflammation of Alzheimer's Disease via the Modulation of Gut Microbiota and Immune System, a Mini-Review

Chen J, Li Q, Zhu J, Yuan Z, Wang T, Song J.

Neurotox Res. 2021 Dec;39(6):2175-2185. doi: 10.1007/s12640-021-00408-z. Epub 2021 Sep 10.

Effectiveness of the 10 cm(2) Rivastigmine Patch in Taiwanese Patients with Mild-to-Moderate Alzheimer's Dementia: A 48-Week Real-World Observational Study

Chang CC, Chan L, Chou HH, Yang YW, Chen TF, Chen TB, Chen CI, Yang A, Hu CJ.

Adv Ther. 2021 Oct;38(10):5286-5301. doi: 10.1007/s12325-021-01893-6. Epub 2021 Sep 10.

Potentiation of microglial endocannabinoid signaling alleviates neuroinflammation in Alzheimer's disease

Rapaka D, Bitra VR, Challa SR, Adiukwu PC.

Neuropeptides. 2021 Dec;90:102196. doi: 10.1016/j.npep.2021.102196. Epub 2021 Sep 2.

Aducanumab Fails to Produce Efficacy Results Yet Obtains US Food and Drug Administration Approval

Angelo M, Ward L.

Popul Health Manag. 2021 Dec;24(6):638-639. doi: 10.1089/pop.2021.0189. Epub 2021 Sep 13.

Preclinical and clinical evidence of NAD(+) precursors in health, disease, and ageing

Reiten OK, Wilvang MA, Mitchell SJ, Hu Z, Fang EF.

Mech Ageing Dev. 2021 Oct;199:111567. doi: 10.1016/j.mad.2021.111567. Epub 2021 Sep 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias